Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]

Teclistamab for patients with heavily pretreated relapsed or refractory...

Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA

$Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )$

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy...

Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA )

Maintenance avelumab plus best supportive care (BSC) versus BSC alone after...

Prof Thomas Powles - Barts Cancer Institute, London, UK

Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma ( Prof Thomas Powles - Barts Cancer Institute, London, UK )

Brigatinib for NSCLC, latest research and overcoming complications

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA

Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )

Sym015 shows superior specificity compared to TKIs for NSCLC

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA

Sym015 shows superior specificity compared to TKIs for NSCLC ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )

Update from KAITLIN for high-risk HER2-positive early breast cancer

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA

Update from KAITLIN for high-risk HER2-positive early breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA...

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )

Better genetic diagnostics in Ugandan breast cancer patients

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA

Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )

COVID-19: Treating breast cancer and the knock on effects of the coronavirus...

Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative...

Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer ( Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain )

COM701 as a monotherapy and in combination with nivolumab for various advanced...

Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA

COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours ( Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA )

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

Dr Edward Garon - UCLA Medical Center, Santa Monica, USA

Do immune checkpoint inhibitors work in EGFR mutant lung cancer? ( Dr Edward Garon - UCLA Medical Center, Santa Monica, USA )

More from ecancer